Lithium Ion

Lithium Ion

SCHEMBL6628951

O=C([O-])n1ccc2ccccc21.[Li+]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.63
TSHR P16473 2/20 0.59
RAB9A P51151 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
KMT2A Q03164 2/20 0.46
TFPI2 P48307 1/20 0.44
NPY4R P50391 1/20 0.44
GAA P10253 1/20 0.44
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNA7 P36544 1/20 0.42
CHRNA4 P43681 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
LMNA P02545 2/20 0.42
CDK4 P11802 3/20 0.41
CCND1 P24385 3/20 0.41
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10477477 0.81 NOTUM (0.70) NOTUMTSHRRAB9AL3MBTL1KMT2A
SCHEMBL1151123 0.81 NOTUM (0.70) NOTUMTSHRRAB9AL3MBTL1KMT2A
SCHEMBL931955 0.79 TSHR (0.69) NOTUMTSHRRAB9AL3MBTL1KMT2A
SCHEMBL29453277 0.79 TSHR (0.69) NOTUMTSHRRAB9AL3MBTL1KMT2A
SCHEMBL3649822 0.78 NOTUM (0.66) NOTUMTSHRRAB9AL3MBTL1KMT2A
SCHEMBL4520021 0.78 NOTUM (0.66) NOTUMTSHRRAB9AL3MBTL1KMT2A
SCHEMBL5638317 0.78 NOTUM (0.66) NOTUMTSHRRAB9AL3MBTL1KMT2A
Hydrochloric Acid SCHEMBL20610213 0.78 TSHR (0.67) NOTUMTSHRRAB9AL3MBTL1KMT2A
SCHEMBL6628956 0.78 TSHR (0.67) NOTUMTSHRRAB9AL3MBTL1KMT2A
SCHEMBL15702556 0.78 NOTUM (0.66) NOTUMTSHRRAB9AL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1088823-B1 Fused pyrrolocarbazoles CEPHALON INC (US) 2004-12-29 EP disclosed
EP-1389194-A2 INHIBITORS OF BACE VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-02-18 EP disclosed
WO-2002088101-A2 INHIBITORS OF BACE VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed
EP-0785938-B1 FUSED PYRROLOCARBAZOLES CEPHALON INC (US) 2002-01-02 EP disclosed
EP-1088823-A1 Fused pyrrolocarbazoles CEPHALON, INC. (US) 2001-04-04 EP disclosed
EP-0885229-B1 FUSED PYRROLO(2,3-C)CARBAZOLE-6-ONES WHICH POTENTIATE ACTIVITY OF GAMMA INTERFERON CEPHALON INC (US) 2000-08-02 EP disclosed
EP-0885229-A1 FUSED PYRROLO(2,3-C)CARBAZOLE-6-ONES WHICH POTENTIATE ACTIVITY OF GAMMA INTERFERON CEPHALON, INC. (US) 1998-12-23 EP disclosed
US-5801190-A Fused pyrrolo 2,3-C! carbazole-6-ones CEPHALON, INC. (US) 1998-09-01 US disclosed
US-5705511-A ENZYME INHIBITORS, ANTIINFLAMMATORY, TROPHIC FACTOR, ANTICANCER CELL GROWTH CEPHALON, INC. (US) 1998-01-06 US disclosed
WO-1997031002-A1 FUSED PYRROLO(2,3-C)CARBAZOLE-6-ONES WHICH POTENTIATE ACTIVITY OF GAMMA INTERFERON CEPHALON, INC. (US) 1997-08-28 WO disclosed
EP-0785938-A1 FUSED PYRROLOCARBAZOLES CEPHALON, INC. (US) 1997-07-30 EP disclosed
US-5616724-A FOR POTENTIATION OF HUMAN INTERFERON-GAMMA; IMMUNOLOGY CEPHALON, INC. (US) 1997-04-01 US disclosed
US-5594009-A KINASE INHIBITORS, TROPHIC FACTOR-INDUCED ACTIVITY ENHANCEMENT, CELL SURVIVAL CEPHALON, INC. (US) 1997-01-14 US disclosed
US-5591855-A KINASE INHIBITORS, TROPHIC FACTOR-INDUCED ACTIVITY ENHANCEMENT, CELL SURVIVAL CEPHALON, INC. (US) 1997-01-07 US disclosed
US-5475110-A Treating nervous system disorders and inflammation, inhibiting protein and tyrosine kinases, inhibiting cell growth CEPHALON, INC. (US) 1995-12-12 US disclosed